InvestorsHub Logo
Followers 826
Posts 119432
Boards Moderated 16
Alias Born 09/05/2002

Re: DewDiligence post# 2543

Thursday, 06/01/2017 10:37:30 AM

Thursday, June 01, 2017 10:37:30 AM

Post# of 2795
OCRX starts phase-2a trial for oral formulation of OCR-002 in cirrhotic patients—results expected by year-end:

#msg-131820624

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.